Articles

SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia

Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
Geisel School of Medicine at Dartmouth, Hanover, NH, USA
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
Geisel School of Medicine at Dartmouth, Hanover, NH, USA
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
Pathology, Portland VA Medical Center, Portland, OR, USA
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
Vol. 102 No. 11 (2017): November, 2017 https://doi.org/10.3324/haematol.2017.170571